Study: Vaporized Cannabis Mitigates Treatment-Resistant Diabetic Neuropathy

Did you know that studies suggest vaporizing cannabis can help reduce the pain associated with Diabetic Peripheral Neuropathy (DPN)?

In a trial conducted at the University of California, San Diego, 16 patients with DPN were administered low, medium, or high doses of THC or placebo. Then, for four hours, the subjects measured their pain intensity (based on the subjective highness score) at the 5, 15, 30, 45, and 60 minute marks, and then every 30 minutes for the last 3 hours.

The investigators concluded, "This small, short-term, placebo-controlled trial of inhaled cannabis demonstrated a dose dependent reduction in diabetic peripheral neuropathy pain in patients with treatment-refractory pain."

This outcome coincides with the results of previous research on cannabis and neuropathic pain performed at the University of California, San Diego, as well as in a larger trial in Israel. Because these results support each other, it serves as further evidence that cannabis is truly effective in treating DPN. (Daily Chronic Analysis) (Study Abstract)